Cancer Cell Research (Online ISSN: 2161-2609)
Current Issue
Vol.7 No.26
Article: Research progress of VEGFR/c-Met dual inhibitors as potent anticancer agents
by Shenglin Luan, Tian Tang, Hongzong Si
Cancer Cell Research 2020 7(26) 687-693; published online 28 May 2020
Abstract:
Vascular endothelial growth factor receptor (VEGFR) is a
vital anticancer target that shows closely correlated with
angiogenesis, cell growth, metastasis, and apoptosis of
cancer cells. Recently, VEGFR inhibitors have become
outstanding therapeutic agents for the treatment of various
solid tumors such as hepatocellular carcinoma, renal cell
carcinoma, medullary thyroid carcinoma, ovarian cancer, etc.
However, it is drug resistance that restricts the long-term
benefits of patients who have received the treatment of
VEGFR inhibitors. Mechanism research revealed that c-Met
overexpression is one of the important factors for the
resistance of VEGFR inhibitors, which is manifested by the
combination therapy of VEGFR and c-Met inhibition. Moreover,
c-Met, the receptor of hepatocyte growth factor (HGF),
elicits many different signaling pathways involved in cell
proliferation, migration, differentiation, and survival,
showing correlation with aggressive tumor growth, poor
prognosis in cancer patients. Thus, small molecules
targeting both VEGFR/c-Met kinases are identified as
effective approaches to treat solid tumors and overcome the
drug resistance of VEGFR inhibitors. Herein, VEGFR/c-Met
inhibitors under clinical evaluation were described for
reviewing the research progress of this area.
Open Access Download (free) PDF
Article: The protective effect on ulcerative colitis of san huang shu’ai decoction by inhibited the IL-1β and telomerase
by Qingmei Mo, Zicong Wu, Yifei Wang, Zhiping Wang
Cancer Cell Research 2020 7(26) 694-698; published online 5 June 2020
Abstract:
Ulcerative colitis (UC) is a chronic inflammatory disease
affecting the colon, and its incidence is rising worldwide.
Patients with ulcerative colitis have mucosal inflammation
starting in the rectum that can extend continuously to
proximal segments of the colon. Ulcerative colitis usually
presents with bloody diarrhoea and is diagnosed by
colonoscopy and histological findings. San huang shu ai
decoction (SH), take in《lei zheng huo ren shu》in Song
Dynasty, composed of coptidis rhizoma(huang lian),
scutellariae radix (huang qin), phellodendri chinensis
cortex (huang bo), and artemisiae argyi folium (ai ye), is a
traditional Chinese medicine formula and is widely used as a
clinically medication formula for its efficiency in
improving hot diarrhoea. But the underlying mechanisms by
which it exerts therapeutic function have not been
thoroughly studied. In this study, acute ulcerative colitis
was induced by oral administration of 2.5% dextran sodium
sulfate for 7 days in drinking water, SH (0.8, 1.6g/kg body
weight respectively) decreased disease activity index and
improved colon length at a certain degree, the expression of
IL-1β, IL-6, TNF-α, MPO, and telomerase in colon of positive
group (sulfasalazine) and SH (low and high doses) group
decreased significantly (P<0.05). These results indicated
that SH can hold protective effect on UC mice, which may be
related to its inhibition of the expression of inflammatory
mediators and oxidative stress in colon, and can be used as
a pharmaceutical preparations for UC treatments.
Open Access Download (free) PDF
Article: Evaluation the effect on ulcerative colitis of traditional Chinese medicine formula huanglian-huangqin herbal pair
by Ziqi Lai, Zicong Wu, Yifei Wang, Zhiping Wang
Cancer Cell Research 2020 7(26) 699-703; published online 5 June 2020
Abstract:
Ulcerative colitis (UC) is a chronic inflammatory disease
affecting the colon, and its incidence is rising worldwide.
Patients with ulcerative colitis have mucosal inflammation
starting in the rectum that can extend continuously to
proximal segments of the colon. Ulcerative colitis usually
presents with bloody diarrhoea and is diagnosed by
colonoscopy and histological findings. Huanglian-huangqin
herbal pair(LQ), a traditional Chinese medicine formula,
composed of coptidis rhizoma(huang lian) and scutellariae
radix(huang qin). Xie xin tang (symopsis of prescriptions of
the Golden chamber, or jin gui yao lue) containing this
herbal pair. LQ is widely used as a clinically medication
formula for its efficiency in inflammatory diseases. But the
underlying mechanisms by which it exerts therapeutic
function of UC has not been thoroughly studied. In this
study, acute ulcerative colitis was induced by oral
administration of 2.5% dextran sodium sulfate for 7 days in
drinking water, LQ (0.9g/kg body weight) decreased disease
activity index and improved colon length at a certain
degree, but compared with positive group(sulfasalazine) has
no statistical significance. These results indicated that LQ
can hold protective effect on UC mice, but can not be used
as a pharmaceutical preparations for UC treatments
pontentionally.
Open Access Download (free) PDF
Article: A bibliometric analysis of research on chimeric antigen receptor T cells
by Yuanming Du, Litao Song, Caide Liu, Jieting Fu, Jiabin Sun, Ying Tang
Cancer Cell Research 2020 7(26) 704-713; published online 15 June 2020
Abstract:
To explore the main authors, institutions, countries,
hotspots and frontiers in the research field of chimeric
antigen receptor T cells (CAR-T). The relevant literature on
chimeric antigen receptor T cells was retrieved from Web of
Science (WOS). The visualization maps were generated by
CiteSpace and VOSviewer. We identified a total of 1644
articles among which 1596 articles were published in
English. We observed rapid growth in the number of articles
after 2010. Mol Ther had the largest number of publications,
while Blood was the most co-cited journal. The USA
contributed most publications. The largest numbers of papers
were written by June Ch. The research in the field of CAR-T
mainly focuses on the basic theory and hematological system
tumors. Conclusion: The USA contributes the most studies on
chimeric antigen receptor T cells. After 2010, relevant
studies increased rapidly. There were active cooperations
between authors, countries, and institutions. Research
hotspots and further research should focus on hematological
tumors and solid tumors.
Open Access Download (free) PDF